| Sana Zekri, MD | |
|
580 Rice St, Saint Paul, MN 55103-2148 | |
| (651) 982-7618 | |
| Not Available |
| Full Name | Sana Zekri |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 580 Rice St, Saint Paul, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013371624 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Healtheast Woodwinds Hospital | Woodbury, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Clinics | 7113830142 | 658 |
News Archive
In a U.S. News & World Report opinion piece, African Health Ministers Aaron Motsoaledi of South Africa, Mphu Ramatlapeng of Lesotho, and Benedict Xaba of Swaziland call upon the international community to join with them in the fight to rid the world of tuberculosis (TB). "That goal might seem overambitious or unrealistic. [But i]t's not," they write
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients' out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.
Presbyterian Intercommunity Hospital (PIH) and Downey Regional Medical Center (DRMC) today announced they had each signed a non-binding letter of intent with plans to execute a definitive agreement calling for PIH's acquisition of DRMC. This will bring together two not-for-profit hospitals both with long standing histories of being dedicated to providing quality care to the communities they serve. The nonbinding letter of intent would allow for the continuation of a nonprofit hospital serving the greater Downey community.
› Verified 8 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
In a U.S. News & World Report opinion piece, African Health Ministers Aaron Motsoaledi of South Africa, Mphu Ramatlapeng of Lesotho, and Benedict Xaba of Swaziland call upon the international community to join with them in the fight to rid the world of tuberculosis (TB). "That goal might seem overambitious or unrealistic. [But i]t's not," they write
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients' out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.
Presbyterian Intercommunity Hospital (PIH) and Downey Regional Medical Center (DRMC) today announced they had each signed a non-binding letter of intent with plans to execute a definitive agreement calling for PIH's acquisition of DRMC. This will bring together two not-for-profit hospitals both with long standing histories of being dedicated to providing quality care to the communities they serve. The nonbinding letter of intent would allow for the continuation of a nonprofit hospital serving the greater Downey community.
› Verified 8 days ago
| Entity Name | Fairview Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
In a U.S. News & World Report opinion piece, African Health Ministers Aaron Motsoaledi of South Africa, Mphu Ramatlapeng of Lesotho, and Benedict Xaba of Swaziland call upon the international community to join with them in the fight to rid the world of tuberculosis (TB). "That goal might seem overambitious or unrealistic. [But i]t's not," they write
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients' out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.
Presbyterian Intercommunity Hospital (PIH) and Downey Regional Medical Center (DRMC) today announced they had each signed a non-binding letter of intent with plans to execute a definitive agreement calling for PIH's acquisition of DRMC. This will bring together two not-for-profit hospitals both with long standing histories of being dedicated to providing quality care to the communities they serve. The nonbinding letter of intent would allow for the continuation of a nonprofit hospital serving the greater Downey community.
› Verified 8 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
In a U.S. News & World Report opinion piece, African Health Ministers Aaron Motsoaledi of South Africa, Mphu Ramatlapeng of Lesotho, and Benedict Xaba of Swaziland call upon the international community to join with them in the fight to rid the world of tuberculosis (TB). "That goal might seem overambitious or unrealistic. [But i]t's not," they write
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients' out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.
Presbyterian Intercommunity Hospital (PIH) and Downey Regional Medical Center (DRMC) today announced they had each signed a non-binding letter of intent with plans to execute a definitive agreement calling for PIH's acquisition of DRMC. This will bring together two not-for-profit hospitals both with long standing histories of being dedicated to providing quality care to the communities they serve. The nonbinding letter of intent would allow for the continuation of a nonprofit hospital serving the greater Downey community.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sana Zekri, MD 580 Rice St, Saint Paul, MN 55103-2148 Ph: (651) 982-7618 | Sana Zekri, MD 580 Rice St, Saint Paul, MN 55103-2148 Ph: (651) 982-7618 |
News Archive
In a U.S. News & World Report opinion piece, African Health Ministers Aaron Motsoaledi of South Africa, Mphu Ramatlapeng of Lesotho, and Benedict Xaba of Swaziland call upon the international community to join with them in the fight to rid the world of tuberculosis (TB). "That goal might seem overambitious or unrealistic. [But i]t's not," they write
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
FibroGen, Inc., today announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company's proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss.
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients' out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.
Presbyterian Intercommunity Hospital (PIH) and Downey Regional Medical Center (DRMC) today announced they had each signed a non-binding letter of intent with plans to execute a definitive agreement calling for PIH's acquisition of DRMC. This will bring together two not-for-profit hospitals both with long standing histories of being dedicated to providing quality care to the communities they serve. The nonbinding letter of intent would allow for the continuation of a nonprofit hospital serving the greater Downey community.
› Verified 8 days ago
Huiying Guo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 Wabasha St S, Saint Paul, MN 55107 Phone: 952-967-5584 | |
David Alan Ness, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 721 Snelling Ave S, Saint Paul, MN 55116 Phone: 651-690-1311 Fax: 651-690-2447 | |
Patrick N Arnold, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 234 Wentworth Ave E, Saint Paul, MN 55118 Phone: 651-455-2940 Fax: 651-455-3354 | |
Laurel Ries, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 980 Rice St, Saint Paul, MN 55117 Phone: 651-326-9020 Fax: 651-326-9021 | |
Dr. Stephanie Dawnonnerate Stanton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Como Ave, Saint Paul, MN 55108 Phone: 952-853-8800 | |
Ravi Balasubrahmanyan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Smith Ave N Ste 4640, Saint Paul, MN 55102 Phone: 651-241-1001 Fax: 651-241-1116 |